BACKGROUND
â– iX Biopharma focuses on the development and commercialisation of innovative therapies for pain management and male erectile dysfunction. The group currently has three drugs under development - WafermineTM, WafernylTM and PheoniXTM, and operates an integrated business model encompassing drug development, manufacturing and supply.
BUSINESS STRATEGY AND FUTURE PLANS
â– Develops and commercialises its products to gain market share in Australia and other parts of the world.
â– Expands portfolio of products by developing a pipeline of products incorporating proprietary drug delivery technology to address unmet or under-served therapeutic needs.
â– Collaborates with third parties to expand product reach into other geographical regions.
Read more »